Carlsmed COO Jeffrey Bertolini sells $3,399 in company stock
Chief Operating Officer at Carlsmed, Inc. (NASDAQ:CARL), Jeffrey Bertolini, parted with 243 shares of the company's common stock on September 30, 2026. The sale, conducted under a Rule 10b5-1 trading plan initiated on March 12, 2026, amounted to $3,399, with each share fetching $13.99. Simultaneously, Mr. Bertolini bolstered his holdings by acquiring 243 shares through the exercise of stock options, which cost him $542 at a rate of $2.232 per share.
The transaction unfolded as CARL shares linger near $13.76, marking a decline of approximately 9% over the past week, despite recording a robust 41% gain over the past half-year. According to InvestingPro analysis, the stock presently manifests as overvalued relative to its Fair Value, with eight supplementary ProTips available to subscribers.
Post these transactions, Mr. Bertolini maintains a direct ownership of 22,489 shares of CARLSMED common stock. The exercised stock options were part of a grant wherein 25% of the initial shares vested on September 30, 2025, with the remainder to vest monthly over 36 months, contingent on his ongoing service. Additionally, Mr. Bertolini retains 5,825 stock options directly.
Carlsmed reported a substantial 57% surge in revenue for the second quarter of 2026, with earnings soaring to $18.9 million from $12.1 million the previous year. The company ascribed this growth to heightened demand for its personalized spine surgery platform and an uptick in procedure volume. Gross margins also widened, prompting Carlsmed to revise its full-year revenue outlook.
Truist Securities responded to these positive developments by elevating its price target for Carlsmed to $20 from $18, while retaining a Buy rating on the stock. The firm credited Carlsmed's stellar second-quarter results and optimistic full-year forecast as the primary drivers behind the upgrade. These recent advancements underscore the company's expanding market footprint and burgeoning customer base.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.